Shenzhen - Delayed Quote CNY

Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ)

10.31 -0.08 (-0.77%)
At close: April 26 at 3:04 PM GMT+8
Key Events
Loading Chart for 300636.SZ
DELL
  • Previous Close 10.39
  • Open 9.00
  • Bid 10.28 x --
  • Ask 10.30 x --
  • Day's Range 9.91 - 10.45
  • 52 Week Range 5.76 - 13.75
  • Volume 10,242,509
  • Avg. Volume 8,748,927
  • Market Cap (intraday) 4.363B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 35.55
  • EPS (TTM) 0.29
  • Earnings Date --
  • Forward Dividend & Yield 0.05 (0.43%)
  • Ex-Dividend Date May 24, 2023
  • 1y Target Est --

Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers raw materials, pharmaceutical intermediates, and fine chemicals. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People's Republic of China.

www.jxsynergy.com

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 300636.SZ

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

300636.SZ
2.18%
SSE Composite Index
3.82%

1-Year Return

300636.SZ
20.36%
SSE Composite Index
5.40%

3-Year Return

300636.SZ
13.74%
SSE Composite Index
11.10%

5-Year Return

300636.SZ
99.47%
SSE Composite Index
1.13%

Compare To: 300636.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300636.SZ

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    4.36B

  • Enterprise Value

    4.72B

  • Trailing P/E

    35.82

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.80

  • Price/Book (mrq)

    1.92

  • Enterprise Value/Revenue

    6.66

  • Enterprise Value/EBITDA

    33.93

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.68%

  • Return on Assets (ttm)

    2.80%

  • Return on Equity (ttm)

    5.98%

  • Revenue (ttm)

    722.14M

  • Net Income Avi to Common (ttm)

    105.98M

  • Diluted EPS (ttm)

    0.29

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    512.75M

  • Total Debt/Equity (mrq)

    34.54%

  • Levered Free Cash Flow (ttm)

    -242.22M

Company Insights: 300636.SZ

People Also Watch